Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice

Bingning Dong, Ying Zhou, Wei Wang, +11

Hepatology

Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis

Jeffrey A. Barnes, Ann S. LaCasce, Yang Feng, +5

Annals of Oncology

Hematological MalignancyLymphoid NeoplasiaMedicineMalignant Blood DisorderImmunology +5

Early-Stage, Lymphocyte-Predominant Hodgkin's Lymphoma: Patient Outcomes From a Large, Single-Institution Series With Long Follow-Up

Ronald C. Chen, Michael S. Chin, Andrea K. Ng, +6

Journal of Clinical Oncology

Lymphocyte-predominant HodgkinPathologyMetronomic ChemotherapyOptimal TreatmentRadiation Oncology +14

Prospective Study of the Efficacy of Breast Magnetic Resonance Imaging and Mammographic Screening in Survivors of Hodgkin Lymphoma

Andrea K. Ng, Judy E. Garber, Lisa Diller, +7

Journal of Clinical Oncology

End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin’s lymphoma

Jeffrey A. Barnes, Ann S. LaCasce, Katherine Zukotynski, +7

Annals of Oncology

Positron Emission TomographyLymphoid NeoplasiaOncologic ImagingMedicineDiagnosis +5

Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors

Suzanne George, Yang Feng, Judith Manola, +10

Cancer

Prognostic and predictive value of an autophagy-related signature for early relapse in stages I–III colon cancer

Shaobo Mo, Weixing Dai, Wenqiang Xiang, +5

Carcinogenesis

Tumor BiologyCell AutophagyAutophagy-related GenesMedicineAutophagy +13

Treatment of primary mediastinal B-cell lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary refractory disease

Jacob D. Soumerai, Matthew D. Hellmann, Yang Feng, +7

Leukemia & lymphoma/Leukemia and lymphoma

Lymphoid NeoplasiaOptimal TherapyRadiation TherapyHigh RateMedicine +11

A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas

Jennifer R. Brown, Jonathan W. Friedberg, Yang Feng, +11

British Journal of Haematology

Surgical OncologyImmunologyPathologyImmunotherapyHematological Malignancy +14

A robust gene signature for the prediction of early relapse in stage I–III colon cancer

Weixing Dai, Yaqi Li, Shaobo Mo, +5

Molecular Oncology

Prognostic BiomarkersColon Cancer PatientsEngineeringMrna SignatureMedicine +13